NCT05331911View on ClinicalTrials.gov

Impact of Propofol-Based Total Intravenous Anesthesia Versus Anesthesia With Sevoflurane on Long-term Outcomes With Patients Undergoing Elective Excision of Primary Liver Tumors

PHASE4RecruitingINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

April 26, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

March 31, 2027

Conditions
Hepatocellular Carcinoma
Interventions
DRUG

Propofol

total intravenous anesthesia with propofol for the partial hepatectomy of hepatocellular carcinoma.

DRUG

Sevoflurane

The sevoflurane group was maintained via sevoflurane vaporizer between 1% and 3% (target minimum alveolar concentration of 0.7-1.3 MAC).

Trial Locations (1)

Unknown

RECRUITING

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City

All Listed Sponsors
collaborator

Tri-Service General Hospital

OTHER

lead

Kaohsiung Medical University Chung-Ho Memorial Hospital

OTHER

NCT05331911 - Impact of Propofol-Based Total Intravenous Anesthesia Versus Anesthesia With Sevoflurane on Long-term Outcomes With Patients Undergoing Elective Excision of Primary Liver Tumors | Biotech Hunter | Biotech Hunter